Every material Form 8-K CDW filed with the SEC in 2025, read and summarized by AI: what happened, the key figures, whether it reads positive or negative for shareholders, and how big a deal it is (impact 1-5). Newest first; each brief links to its own page and to the filing on SEC.gov.
CDW LLC entered a new five-year senior unsecured credit facility totaling $2,884.5 million, dated December 17, 2025, which consolidates, refinances and replaces its prior term and revolving loan agreements from December 1, 2021. The filing says loan proceeds will be used for working capital, general corporate purposes and refinancing the prior loans, and it does not report any financial results. Separately, four named executives' compensation protection agreements were extended three years to January 1, 2029.
Term loan of $634.5 million, fully funded on December 17, 2025, plus a revolving loan facility of $2,250.0 million
Replaces the prior term and revolving loan agreements dated December 1, 2021, with JPMorgan Chase Bank, N.A. as administrative agent
Maximum leverage ratio covenant of 4.00:1.00; revolver can be extended by up to two 1-year periods
Christine A. Leahy, Albert J. Miralles, Frederick J. Kulevich and Katherine E. Sanderson had agreements extended from January 1, 2026 to January 1, 2029
CDW reported third quarter 2025 results on November 4, 2025. Net sales rose 4.0% to $5.7 billion, but operating income fell 8.0% to $443 million and GAAP diluted earnings per share fell 5.8% to $2.21. The board also declared a quarterly dividend of $0.630 per share.
Net sales were $5,737 million versus $5,517 million a year earlier; Corporate rose 4.4%, Small Business 14.2%, and Public 0.6%.
Operating income was $443 million, down 8.0%; gross profit margin was 21.9% versus 21.8%.
Non-GAAP diluted EPS rose 3.0% to $2.71 from $2.63; GAAP diluted EPS was $2.21 versus $2.34.
Dividend of $0.630 per share is payable December 10, 2025 to holders of record as of November 25, 2025.
CDW Corporation said its Chief Growth and Innovation Officer and Executive Vice President, Sona Chawla, will retire effective December 31, 2025. She will serve as a consultant until April 9, 2026 to help with the transition of her duties.
Sona Chawla retires as Chief Growth and Innovation Officer and Executive Vice President effective December 31, 2025
Chawla will be available on a consulting basis until April 9, 2026 to assist with the transition
The filing does not name a successor or state any financial impact
CDW reported second quarter 2025 results on August 6, 2025, with net sales up 10.2% to $5.98 billion, while GAAP operating income fell 3.0% to $420 million and GAAP net income fell 3.5% to $271 million. Non-GAAP net income per diluted share rose 3.9% to $2.60, and the Board declared a $0.625 quarterly dividend payable September 10, 2025.
Net sales were $5.98 billion, up 10.2% from $5.42 billion in the second quarter of 2024.
Gross profit margin fell to 20.8% from 21.8%, and operating income declined 3.0% to $420 million.
Diluted net income per share was $2.05, down 1.2% from $2.07; non-GAAP diluted EPS was $2.60, up 3.9% from $2.50.
The quarterly dividend is $0.625 per share, payable September 10, 2025, to holders of record on August 25, 2025.
CDW reported first quarter 2025 net sales of $5.2 billion, up 6.7% from a year earlier, and GAAP diluted earnings per share of $1.69, up from $1.59. The company also declared a quarterly cash dividend of $0.625 per share, payable June 10, 2025, but gross profit margin slipped to 21.6% from 21.8%.
Net sales were $5,199.1 million, up 6.7% from $4,872.7 million; average daily sales rose 8.4%
GAAP diluted EPS was $1.69 versus $1.59; non-GAAP diluted EPS was $2.15 versus $1.92, up 11.9%
Gross profit margin was 21.6% versus 21.8%, which the company attributed to a higher mix of lower-margin notebooks and mobile devices
Quarterly dividend of $0.625 per share is payable June 10, 2025 to holders of record as of May 26, 2025
CDW reported fourth-quarter 2024 net sales up 3.3% to $5.2 billion, but net income fell 10.8% and diluted EPS fell 9.8% to $1.97, while full-year net sales declined 1.8% to $21.0 billion. The company also raised its share repurchase authorization by $750 million and declared a quarterly dividend of $0.625 per share.
Q4 2024 net sales were $5.2 billion, up 3.3% from $5.0 billion, while gross profit margin fell to 22.3% from 23.0%.
Q4 2024 diluted EPS was $1.97 versus $2.18 a year earlier; full-year 2024 diluted EPS was $7.97 versus $8.10.
Board authorized a $750 million increase to the buyback program, incremental to $588 million unused as of December 31, 2024.
Quarterly dividend of $0.625 per share is payable March 11, 2025 to holders of record on February 25, 2025.
Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.
Only material 8-Ks get a brief: results, deals, executive changes, restructuring, impairments, delisting notices, restatements, cybersecurity incidents and other disclosed events. Routine filings (vote results, exhibits only) are skipped. Every CDW filing is on SEC EDGAR ↗. 8-K briefs of other companies →